Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Enduro Genetics Aps currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is being reviewed by 1 distinct examiner, which represents a focused point of contact for the company's prosecution efforts. The data indicates that 1 distinct art unit is involved, suggesting that the technical scope of the application is confined to a specific examination group at the USPTO. This lack of fragmentation allows for a streamlined legal strategy focused on a single set of technical requirements. The presence of 1 pending office action indicates a very specific focus for the company's current intellectual property efforts.
The busiest examiner for this portfolio is EDWARDS, JESSICA FAYE, who is responsible for 1 pending office action. With a busiest examiner pending count of 1, this individual manages all active prosecution for the company. The presence of 1 distinct examiner and 1 distinct art unit means that the portfolio's progress is tied directly to the resolution of this 1 pending office action. For the applicant, this concentration simplifies administrative tasks but places a high importance on the specific interaction with the 1 assigned examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EDWARDS, JESSICA FAYE | 1 | 38.3% | +47.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18683429 | BURDEN-ADDICTED PRODUCTION STRAINS | EDWARDS, JESSICA FAYE | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18683429 | BURDEN-ADDICTED PRODUCTION STRAINS | EDWARDS, JESSICA FAYE | 1657 | §102§103§112DP | Non-Final OA | — | Pending | Feb 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEnduro Genetics Aps has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jessica Faye Edwards has the most, with 1 of Enduro Genetics Aps's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
